Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells

PLoS Pathogens

Volumn 11, Issue 10, 2015, Pages

  Nawandar, Dhananjay M ^a,b   Wang, Anqi ^a,b   Makielski, Kathleen ^a   Lee, Denis ^a   Ma, Shidong ^a   Barlow, Elizabeth ^a   Reusch, Jessica ^a,b   Jiang, Ru ^c,e   Wille, Coral K ^a,b   Greenspan, Deborah ^d   Greenspan, John S ^d   Mertz, Janet E ^a   Hutt Fletcher, Lindsey ^c   Johannsen, Eric C ^a,b   Lambert, Paul F ^a   Kenney, Shannon C ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; KRUPPEL LIKE FACTOR 4; RNA POLYMERASE II; KRUPPEL LIKE FACTOR; PRDM1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CRISPR CAS SYSTEM; CRISPR CAS9 SYSTEM; DNA REPLICATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CONSTRUCT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MUTAGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TRANSIENT TRANSFECTION; ADULT; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; HAIRY LEUKOPLAKIA; HOST PATHOGEN INTERACTION; LASER CAPTURE MICRODISSECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

ADULT; CELL DIFFERENTIATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LASER CAPTURE MICRODISSECTION; LEUKOPLAKIA, HAIRY; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84946085231     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005195     Document Type: Article

References (99)

1. Henle G, Henle W, Diehl V, Relation of Burkitt’s tumor-associated herpes-y type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968;59: 94–101. 5242134
2. Rickinson A. B., Kieff Elliot, Epstein-Barr Virus. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer Health/ Lippincott Williams & Wilkins; 2007. pp. 2655–2700.
3. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970;228: 1056–1058. 4320657
4. Kieff Elliot D, Rickinson A. B., Epstein-Barr Virus and Its Replication. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer Health/ Lippincott Williams & Wilkins; 2007. pp. 2603–2654.
5. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA, Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A. 2005;102: 18093–18098. 16330748
6. Laichalk LL, Thorley-Lawson DA, Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. 2005;79: 1296–1307. 15613356
7. Tovey MG, Lenoir G, Begon-Lours J, Activation of latent Epstein-Barr virus by antibody to human IgM. Nature. 1978;276: 270–272. 213727
8. Takada K, Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer J Int Cancer. 1984;33: 27–32.
9. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, et al. Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985;313: 1564–1571. 2999595
10. Walling DM, Flaitz CM, Nichols CM, Hudnall SD, Adler-Storthz K, Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J Infect Dis. 2001;184: 1499–1507. 11740724
11. Webster-Cyriaque J, Middeldorp J, Raab-Traub N, Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections. J Virol. 2000;74: 7610–7618. 10906215
12. Tsang CM, Yip YL, Lo KW, Deng W, To KF, Hau PM, et al. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci. 2012;109: E3473–E3482. doi: 10.1073/pnas.1202637109 23161911
13. Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol. 1991;65: 2868–2874. 1851858
14. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N, Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A. 1990;87: 8790–8794. 2174165
15. Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE, Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. Proc Natl Acad Sci U S A. 2014;111: 16544–16549. doi: 10.1073/pnas.1400818111 25313069
16. Hummel M, Hudson JB, Laimins LA, Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol. 1992;66: 6070–6080. 1326657
17. Flores ER, Lambert PF, Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol. 1997;71: 7167–7179. 9311789
18. Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe C, Delecluse H-J, Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer J Int Cancer. 2007;121: 588–594.
19. Karimi L, Crawford DH, Speck S, Nicholson LJ, Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. J Gen Virol. 1995;76 (Pt 4): 759–765. 9049321
20. Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, et al. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 1992;356: 347–350. 1312681
21. Knox PG, Li QX, Rickinson AB, Young LS, In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology. 1996;215: 40–50. 8553585
22. Andrei G, Duraffour S, Van den Oord J, Snoeck R, Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents. Antiviral Res. 2010;85: 431–449. doi: 10.1016/j.antiviral.2009.10.019 19883696
23. Countryman J, Jenson H, Seibl R, Wolf H, Miller G, Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol. 1987;61: 3672–3679. 2824806
24. Countryman J, Miller G, Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci. 1985;82: 4085–4089. 2987963
25. Ragoczy T, Heston L, Miller G, The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes. J Virol. 1998;72: 7978–7984. 9733836
26. Takada K, Shimizu N, Sakuma S, Ono Y, trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol. 1986;57: 1016–1022. 3005608
27. Zalani S, Holley-Guthrie E, Kenney S, Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A. 1996;93: 9194–9199. 8799177
28. Rooney CM, Rowe DT, Ragot T, Farrell PJ, The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol. 1989;63: 3109–3116. 2542618
29. Speck SH, Chatila T, Flemington E, Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 1997;5: 399–405. 9351176
30. Kenney SC, Mertz JE, Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol. 2014;26: 60–68. doi: 10.1016/j.semcancer.2014.01.002 24457012
31. Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A, Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 1986;5: 3243–3249. 3028777
32. Cox MA, Leahy J, Hardwick JM, An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol. 1990;64: 313–321. 2152819
33. Hardwick JM, Lieberman PM, Hayward SD, A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol. 1988;62: 2274–2284. 2836611
34. Holley-Guthrie EA, Quinlivan EB, Mar EC, Kenney S, The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J Virol. 1990;64: 3753–3759. 2164595
35. Kenney S, Holley-Guthrie E, Mar EC, Smith M, The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J Virol. 1989;63: 3878–3883. 2548003
36. Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC, Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J Virol. 2013;87: 935–950. doi: 10.1128/JVI.01790-12 23135711
37. Magnúsdóttir E, Kalachikov S, Mizukoshi K, Savitsky D, Ishida-Yamamoto A, Panteleyev AA, et al. Epidermal terminal differentiation depends on B lymphocyte-induced maturation protein-1. Proc Natl Acad Sci U S A. 2007;104: 14988–14993. 17846422
38. Turner CA, Mack DH, Davis MM, Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell. 1994;77: 297–306. 8168136
39. Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE, Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters. J Virol. 2015;89: 1731–1743. doi: 10.1128/JVI.02781-14 25410866
40. Segre JA, Bauer C, Fuchs E, Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet. 1999;22: 356–360. 10431239
41. Cordani N, Pozzi S, Martynova E, Fanoni D, Borrelli S, Alotto D, et al. Mutant p53 subverts p63 control over KLF4 expression in keratinocytes. Oncogene. 2011;30: 922–932. doi: 10.1038/onc.2010.474 20972454
42. Birdwell CE, Queen KJ, Kilgore PCSR, Rollyson P, Trutschl M, Cvek U, et al. Genome-Wide DNA Methylation as an Epigenetic Consequence of Epstein-Barr Virus Infection of Immortalized Keratinocytes. J Virol. 2014;88: 11442–11458. doi: 10.1128/JVI.00972-14 25056883
43. McMullan R, Lax S, Robertson VH, Radford DJ, Broad S, Watt FM, et al. Keratinocyte differentiation is regulated by the Rho and ROCK signaling pathway. Curr Biol CB. 2003;13: 2185–2189. 14680635
44. Chew YC, Adhikary G, Xu W, Wilson GM, Eckert RL, Protein kinase C δ increases Kruppel-like factor 4 protein, which drives involucrin gene transcription in differentiating keratinocytes. J Biol Chem. 2013;288: 17759–17768. doi: 10.1074/jbc.M113.477133 23599428
45. Zalani S, Holley-Guthrie EA, Gutsch DE, Kenney SC, The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. J Virol. 1992;66: 7282–7292. 1331521
46. Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T, Contribution of Myocyte Enhancer Factor 2 (MEF2) Family Transcription Factors to BZLF1 Expression in Epstein-Barr virus Reactivation from Latency. J Virol. 2013.
47. Jiang W, Lobo-Ruppert SM, Ruppert JM, Bad things happen in the basal layer: KLF4 and squamous cell carcinoma. Cancer Biol Ther. 2008;7: 783–785. 18424916
48. Buettner M, Lang A, Tudor CS, Meyer B, Cruchley A, Barros MHM, et al. Lytic Epstein-Barr virus infection in epithelial cells but not in B-lymphocytes is dependent on Blimp1. J Gen Virol. 2012;93: 1059–1064. doi: 10.1099/vir.0.038661-0 22278826
49. Hu S, Wan J, Su Y, Song Q, Zeng Y, Nguyen HN, et al. DNA methylation presents distinct binding sites for human transcription factors. eLife. 2013;2: e00726. doi: 10.7554/eLife.00726 24015356
50. Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PWTC, Bauer C, et al. Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives. Cell. 2013;152: 1146–1159. doi: 10.1016/j.cell.2013.02.004 23434322
51. Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q, Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins. BMC Cancer. 2012;12: 125. doi: 10.1186/1471-2407-12-125 22458933
52. Feng W, Kraus RJ, Dickerson SJ, Lim HJ, Jones RJ, Yu X, et al. ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS Cells. J Virol. 2007;81: 10113–10122. 17626078
53. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med. 2008;6: 32. doi: 10.1186/1479-5876-6-32 18570662
54. Liu Z, Yang H, Luo W, Jiang Q, Mai C, Chen Y, et al. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma. Histopathology. 2013;63: 362–370. doi: 10.1111/his.12176 23758499
55. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347: 1260419. doi: 10.1126/science.1260419 25613900
56. Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, et al. Down-regulation of Krüppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-β and Bone Morphogenetic Protein 4. J Biol Chem. 2011;286: 28097–28110. doi: 10.1074/jbc.M111.236950 21673106
57. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA, Kruppel-like factor 4 (KLF4) inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem. 2010; jbc.M110.114546.
58. Mahatan CS, Kaestner KH, Geiman DE, Yang VW, Characterization of the structure and regulation of the murine gene encoding gut-enriched Krüppel-like factor (Krüppel-like factor 4). Nucleic Acids Res. 1999;27: 4562–4569. 10556311
59. Chen X, Whitney EM, Gao SY, Yang VW, Transcriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol. 2003;326: 665–677. 12581631
60. Rowland BD, Bernards R, Peeper DS, The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 2005;7: 1074–1082. 16244670
61. Chen ZY, Shie J-L, Tseng C-C, Gut-enriched Kruppel-like factor represses ornithine decarboxylase gene expression and functions as checkpoint regulator in colonic cancer cells. J Biol Chem. 2002;277: 46831–46839. 12297499
62. Takahashi K, Yamanaka S, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126: 663–676. 16904174
63. Soufi A, Donahue G, Zaret KS, Facilitators and Impediments of the Pluripotency Reprogramming Factors’ Initial Engagement with the Genome. Cell. 2012;151: 994–1004. doi: 10.1016/j.cell.2012.09.045 23159369
64. Salmon M, Gomez D, Greene E, Shankman L, Owens GK, Cooperative Binding of KLF4, pELK-1, and HDAC2 to a G/C Repressor Element in the SM22α Promoter Mediates Transcriptional Silencing During SMC Phenotypic Switching In Vivo. Circ Res. 2012;111: 685–696. doi: 10.1161/CIRCRESAHA.112.269811 22811558
65. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, et al. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005;65: 2746–2754. 15805274
66. Zhang N, Zhang J, Shuai L, Zha L, He M, Huang Z, et al. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer. Int J Oncol. 2012;40: 2038–2048. doi: 10.3892/ijo.2012.1395 22407433
67. Krstic M, Stojnev S, Jovanovic L, Marjanovic G, KLF4 expression and apoptosis-related markers in gastric cancer. J BUON Off J Balk Union Oncol. 2013;18: 695–702.
68. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW, Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene. 2004;23: 395–402. 14724568
69. Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 2005;24: 1491–1500. 15674344
70. Liu Z, Teng L, Bailey SK, Frost AR, Bland KI, LoBuglio AF, et al. Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling. Cancer Biol Ther. 2009;8: 1840–1851. 19717984
71. Tai S-K, Yang M-H, Chang S-Y, Chang Y-C, Li W-Y, Tsai T-L, et al. Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci. 2011;102: 895–902. doi: 10.1111/j.1349-7006.2011.01859.x 21219537
72. Evans PM, Zhang W, Chen X, Yang J, Bhakat KK, Liu C, Krüppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation. J Biol Chem. 2007;282: 33994–34002. 17908689
73. Du JX, McConnell BB, Yang VW, A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Krüppel-like factor 4. J Biol Chem. 2010;285: 28298–28308. doi: 10.1074/jbc.M110.101717 20584900
74. Chen ZY, Wang X, Zhou Y, Offner G, Tseng C-C, Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res. 2005;65: 10394–10400. 16288030
75. Kim MO, Kim S-H, Cho Y-Y, Nadas J, Jeong C-H, Yao K, et al. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nat Struct Mol Biol. 2012;19: 283–290. doi: 10.1038/nsmb.2217 22307056
76. Zheng B, Bernier M, Zhang X-H, Suzuki T, Nie C-Q, Li YH, et al. miR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation. J Mol Cell Cardiol. 2015;82: 201–212. doi: 10.1016/j.yjmcc.2015.03.011 25791170
77. Tahmasebi S, Ghorbani M, Savage P, Yan K, Gocevski G, Xiao L, et al. Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation. J Biol Chem. 2013;288: 12791–12804. doi: 10.1074/jbc.M113.465443 23515309
78. Yusuf I, Kharas MG, Chen J, Peralta RQ, Maruniak A, Sareen P, et al. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol. 2008;20: 671–681. doi: 10.1093/intimm/dxn024 18375530
79. Kharas MG, Yusuf I, Scarfone VM, Yang VW, Segre JA, Huettner CS, et al. KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood. 2007;109: 747–755. 16954505
80. Guan H, Xie L, Leithäuser F, Flossbach L, Möller P, Wirth T, et al. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood. 2010;116: 1469–1478. doi: 10.1182/blood-2009-12-256446 20519630
81. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 2002;17: 51–62. 12150891
82. Lin K-I, Angelin-Duclos C, Kuo TC, Calame K, Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol. 2002;22: 4771–4780. 12052884
83. Lin Y, Wong K, Calame K, Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science. 1997;276: 596–599. 9110979
84. Keller AD, Maniatis T, Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev. 1991;5: 868–879. 1851123
85. Piboonniyom S, Duensing S, Swilling NW, Hasskarl J, Hinds PW, Münger K, Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res. 2003;63: 476–483. 12543805
86. Kanda T, Yajima M, Ahsan N, Tanaka M, Takada K, Production of High-Titer Epstein-Barr Virus Recombinants Derived from Akata Cells by Using a Bacterial Artificial Chromosome System. J Virol. 2004;78: 7004–7015. 15194777
87. Strong MJ, Baddoo M, Nanbo A, Xu M, Puetter A, Lin Z, Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J Virol. 2014;88: 10696–10704. doi: 10.1128/JVI.01457-14 24991015
88. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer J Int Cancer. 1999;83: 121–126.
89. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, et al. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer J Int Cancer. 1997;70: 443–449.
90. Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM, Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol. 2000;74: 6324–6332. 10864642
91. Lin C-C, Liu L-Z, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM, A KLF4–miRNA-206 Autoregulatory Feedback Loop Can Promote or Inhibit Protein Translation Depending upon Cell Context. Mol Cell Biol. 2011;31: 2513–2527. doi: 10.1128/MCB.01189-10 21518959
92. Györy I, Fejér G, Ghosh N, Seto E, Wright KL, Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines. J Immunol. 2003;170: 3125–3133. 12626569
93. Klug M, Rehli M, Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics Off J DNA Methylation Soc. 2006;1: 127–130.
94. Balsitis SJ, Sage J, Duensing S, Münger K, Jacks T, Lambert PF, Recapitulation of the Effects of the Human Papillomavirus Type 16 E7 Oncogene on Mouse Epithelium by Somatic Rb Deletion and Detection of pRb-Independent Effects of E7 In Vivo. Mol Cell Biol. 2003;23: 9094–9103. 14645521
95. Ma S-D, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, et al. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol. 2012;86: 7976–7987. doi: 10.1128/JVI.00770-12 22623780
96. Adamson AL, Kenney S, Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol. 2001;75: 2388–2399. 11160742
97. Hong GK, Delecluse H-J, Gruffat H, Morrison TE, Feng W-H, Sergeant A, et al. The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1. J Virol. 2004;78: 4983–4992. 15113878
98. Sanjana NE, Shalem O, Zhang F, Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11: 783–784. doi: 10.1038/nmeth.3047 25075903
99. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343: 84–87. doi: 10.1126/science.1247005 24336571